Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NEOG · against 353 other Healthcare companies of similar size
Ranked #293 of 354 · scores higher than 17% of peers · safety percentile 18
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)31 peers with a safety percentile of 10–19, including NEOG · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | NEOG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 339 reported | 0.37× | 0.23× | 36% | 33% | |
| BetaLower is better · 339 reported | 1.79 | 0.57 | 8% | 33% | |
| Current ratioHigher is better · 340 reported | 3.90× | 2.81× | 63% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 2.6B USD | 100 | 43 | |
| 3 | 3.6B USD | 99 | ||
| 4 | 1.8B USD | 99 | 42 | |
| 5 | 2.2B USD | 99 | 48 | |
| 289 | 2.0B USD | 21 | 29 | |
| 290 | 1.4B USD | 20 | 42 | |
| 291 | 168.6B INR (≈$2.0B) | 20 | 63 | |
| 292 | 1.5B USD | 19 | 26 | |
| 293 | 2.6B USD | 18 | 32 | |
| 294 | 4.4B AUD (≈$2.9B) | 18 | 51 | |
| 295 | 12.7B CNY (≈$1.8B) | 18 | 20 | |
| 296 | 2.8B USD | 17 | 33 | |
| 297 | 1.5B EUR (≈$1.6B) | 17 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score